Stuart A Callary1, John R Field, David G Campbell. 1. Centre for Orthopaedic and Trauma Research, Level 4 Bice Building, University of Adelaide and Royal Adelaide Hospital, North Terrace, Adelaide, 5000, South Australia, Australia, stuart.callary@health.sa.gov.au.
Abstract
BACKGROUND: A sequentially irradiated and annealed, second-generation highly crosslinked polyethylene (XLPE) liner was introduced clinically in 2005 to reduce in vivo oxidation. This liner design has also been shown to reduce wear in vitro when compared with conventional and first-generation crosslinked liners. To date, there is only one study reporting an in vivo wear rate of this liner at 5 years' followup. However, that study used measurements made from plain radiographs, which have limited sensitivity, particularly when monitoring very low amounts of wear. QUESTIONS/PURPOSES: What is the amount and direction of wear at 5 years using radiostereometric analysis (RSA) in patients who had THAs that included second-generation XLPE? METHODS: We prospectively reviewed 21 patients who underwent primary cementless THA with the same design of XLPE acetabular liner and 32-mm articulation. Tantalum markers were inserted during surgery and all patients had RSA radiographs at 1 week, 6 months, and 1, 2, and 5 years postoperatively. Femoral head penetration within the acetabular component was measured with UmRSA(®) software. One patient died and two had incomplete radiographs leaving 18 radiographic series for analysis. RESULTS: The mean amounts of proximal, two-dimensional, and three-dimensional head penetration between 1 week and 5 years were 0.018, 0.071, and 0.149 mm, respectively. The mean proximal, two-dimensional, and three-dimensional wear rates calculated between 1 year and 5 years were all less than 0.001 mm/year with no patient recording a wear rate of more than 0.040 mm/year. CONCLUSIONS: The head penetration of a second-generation XLPE liner remained low at 5 years and the wear rate calculated after the first year was low in all directions. This low level of wear remains encouraging for the future clinical performance of this material.
BACKGROUND: A sequentially irradiated and annealed, second-generation highly crosslinked polyethylene (XLPE) liner was introduced clinically in 2005 to reduce in vivo oxidation. This liner design has also been shown to reduce wear in vitro when compared with conventional and first-generation crosslinked liners. To date, there is only one study reporting an in vivo wear rate of this liner at 5 years' followup. However, that study used measurements made from plain radiographs, which have limited sensitivity, particularly when monitoring very low amounts of wear. QUESTIONS/PURPOSES: What is the amount and direction of wear at 5 years using radiostereometric analysis (RSA) in patients who had THAs that included second-generation XLPE? METHODS: We prospectively reviewed 21 patients who underwent primary cementless THA with the same design of XLPE acetabular liner and 32-mm articulation. Tantalum markers were inserted during surgery and all patients had RSA radiographs at 1 week, 6 months, and 1, 2, and 5 years postoperatively. Femoral head penetration within the acetabular component was measured with UmRSA(®) software. One patient died and two had incomplete radiographs leaving 18 radiographic series for analysis. RESULTS: The mean amounts of proximal, two-dimensional, and three-dimensional head penetration between 1 week and 5 years were 0.018, 0.071, and 0.149 mm, respectively. The mean proximal, two-dimensional, and three-dimensional wear rates calculated between 1 year and 5 years were all less than 0.001 mm/year with no patient recording a wear rate of more than 0.040 mm/year. CONCLUSIONS: The head penetration of a second-generation XLPE liner remained low at 5 years and the wear rate calculated after the first year was low in all directions. This low level of wear remains encouraging for the future clinical performance of this material.
Authors: Edward Ebramzadeh; Sophia N Sangiorgio; Federico Lattuada; Joon-Soon Kang; Roberto Chiesa; Harry A McKellop; Lawrence D Dorr Journal: J Bone Joint Surg Am Date: 2003-12 Impact factor: 5.284
Authors: Andrew J Hui; Richard W McCalden; John M Martell; Steven J MacDonald; Robert B Bourne; Cecil H Rorabeck Journal: J Bone Joint Surg Am Date: 2003-03 Impact factor: 5.284
Authors: Charles R Bragdon; John M Martell; Meridith E Greene; Daniel M Estok; Jonas Thanner; Johan Kärrholm; William H Harris; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2006-07 Impact factor: 4.176
Authors: John H Dumbleton; James A D'Antonio; Michael T Manley; William N Capello; Aiguo Wang Journal: Clin Orthop Relat Res Date: 2006-12 Impact factor: 4.176
Authors: Stuart A Callary; David G Campbell; Graham Mercer; Kjell G Nilsson; John R Field Journal: Clin Orthop Relat Res Date: 2013-01-19 Impact factor: 4.176
Authors: Jean-Alain Epinette; Steven F Harwin; Fiachra E Rowan; Philippe Tracol; Michael A Mont; Morad Chughtai; Geoffrey H Westrich Journal: Int Orthop Date: 2016-12-24 Impact factor: 3.075
Authors: Cody C Wyles; Joseph A Panos; Matthew T Houdek; Robert T Trousdale; Daniel J Berry; Michael J Taunton Journal: J Arthroplasty Date: 2018-10-30 Impact factor: 4.757
Authors: Kamal Bali; Richard W McCalden; Douglas D R Naudie; Steven J MacDonald; Matthew G Teeter Journal: Clin Orthop Relat Res Date: 2016-02 Impact factor: 4.176
Authors: Stuart A Callary; Lucian B Solomon; Oksana T Holubowycz; David G Campbell; Zachary Munn; Donald W Howie Journal: Acta Orthop Date: 2014-10-10 Impact factor: 3.717